The World Obesity Federation receives funding from a variety of sources to support its programmes and core activities.
We receive significant core funding to support our mission through sales of our journals - Obesity Reviews, Pediatric Obesity, Obesity Science and Practice, and Clinical Obesity - and through SCOPE certification and fees. Further support is provided through our members and income from regional and global congresses including the International Congress on Obesity. WOF receives funding in the form of project and educational grants from sources including Novo Nordisk, Pfizer, Lilly, Medtronic, Gelesis, Johnson & Johnson, WW, Rhythm Pharmaceutical, Vivus, IFA and Boehringer Ingelheim. We have received grants from TCC Foundation and World Heart Federation.
View the World Obesity Federations annual reports and financial documents here. Click to download the required files.